Pieter Wasmuth, CFO of REpower Systems AG, leaves the company per 31 August 2009
The term of his service contract was regularly to expire at the end of November 2009 but both parties have mutually agreed on a termination as per 31 August 2009.
As CFO of REpower Systems AG, Pieter Wasmuth has successfully accompanied three capital increases and only recently successfully negotiated a Syndicated Financing Facility Agreement. During his time in office, in four and a half years, the company successfully continued its international growth and Mr. Wasmuth played an important role in the setup of its joint venture activities in Portugal and China as well as the establishing of subsidiaries in Spain, Italy, France and other countries.
Mr. Tulsi R. Tanti, Chairman of the Supervisory Board of REpower Systems AG, said: "On behalf of the entire supervisory board I thank Mr. Wasmuth for his successful commitment. I acknowledge him as a very entrepreneurial person with an excellent finance background and an outstanding business sense, and wish him all the best for the future. "
REpower Systems AG is one of the leading manufacturers of onshore and offshore wind turbines. The international mechanical engineering company develops produces and markets wind turbines with rated outputs of 2 MW to 6.15 MW and rotor diameters of 82 metres to 126 metres for almost any location. In addition to this, it offers an extensive range of service and maintenance services. The profitable and reliable systems are designed at the REpower development centre in Rendsburg and manufactured at its Husum (North Friesland), Trampe (Brandenburg) and Bremerhaven plants.
The company, which is headquartered in Hamburg and has been listed since March 2002, has over 1,700 employees worldwide and can draw on experience gained in the manufacture and installation of almost 2,000 wind turbines worldwide. REpower is represented by distribution partners, subsidiaries and participations in European markets such as France, Belgium, Great Britain, Italy, Portugal and Spain as well as on a global level in the USA, Japan, China, Australia and Canada.